https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MC.jpg

Atherectomy Devices Market Analysis | Europe | 2020-2026 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Pages: 59
  • Published Date: 8/1/2016
  • Type: MedCore

The market is experiencing higher growth in below-the-knee procedures. Several clinical trials, including the Determination of Effectiveness of SilverHawk™/TurboHawk™ Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities (DEFINITIVE LE) and Orbital Atherectomy System for the Treatment of Peripheral Vascular Stenosis (OASIS) trials have produced encouraging results for atherectomy device usage.

Atherectomy is a procedure used for removing plaque deposits from arteries. They have traditionally been more effective in peripheral than coronary applications. The success of atherectomies has been driven by the limited performance of existing treatments. Often a blockage is alleviated above the knee, only to have the blood flow deteriorate due to further bottlenecks below the knee. Failure to resolve these vascular limitations can result in critical limb ischemia, ulceration, limb pain or eventual amputation, if left untreated.

Segments Covered in This Market

  • Atherectomy Device Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the many companies in the European Athrectomy Device market, Medtronic was the leader, followed by Spectranetics and Boston Scientific. Medtronic acquired Covidien in 2015. Prior to the acquisition Covidien was the leading competitor in the market. Covidien acquired ev3 in 2010. Previous to this acquisition, ev3 had been the market leader since 2007, when they acquired FoxHollow’s SilverHawk® family of products.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Europe Market Report Suite for Peripheral Vascular Devices – MedSuite

Learn More about these product types
 

FREE Sample Report



The "European Market Report Suite for Peripheral Vascular Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Medtronic
Cook Medical
Boston Scientific
Cardinal Health
Abbott Laboratories
W. L. Gore
C. R. Bard
Terumo
St. Jude Medical
Straub Medical
Maquet
Biotronik
Others include: Aachen Resonance GmbH, ALN Implants chirurgicaux, AngioSlide, Argon Medical, Asahi Intec Co., Avinger, B. Braun, Biotronik, Blockade Medical, Bolton Medical, BTG, Cardiva, Celenova, CID SpA, Creagh Medical, Endologix, EndoShape, HemCon Medical Technologies, Jotec Gmbh, Lombard Medical, Marine Polymer Technologies, Merit Medical Systems, Inc., Morris Innovative, Inc., Nantec Medical, Nordion, OptiMed Gmbh, Oscor Inc., Penumbra, Philips, Pfizer, Rafael Medical Technologies, Sirtex Medical, Spectranetics, Teleflex Medical, TriReme Medical, TZ Medical, Vascular Flow Technologies, Vascular Solutions, Vasorum, Vivasure Medical, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary FREE

Atherectomy Devices Market Analysis | Europe | 2020-2026 | MedCore

$295$6,995

Atherectomy is a procedure used for removing plaque deposits from arteries. They have traditionally been more effective in peripheral than coronary applications. The success of atherectomies has been driven by the limited performance of existing treatments. Often a blockage is alleviated above the knee, only to have the blood flow deteriorate due to further bottlenecks below the knee. Failure to resolve these vascular limitations can result in critical limb ischemia, ulceration, limb pain or eventual amputation, if left untreated.

  • 2017
  • 2013-2023
  • Europe
  • 8/1/2016
  • 59
  • MedCore
Clear
Request Sample Sheets Request Customization